{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-027746","form_type":"8-K","ticker":"PURE","cik":"0001006028","company_name":"PURE BIOSCIENCE, INC.","filed_at":"2025-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.497118+00:00","generated_at":"2026-05-16T13:09:31.377756+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"PURE Bioscience reports fiscal Q1 2026 revenue up 27% to $707K, net loss narrows to $464K","bullets":["Net product sales $707K for Q1 ended Oct 31, 2025, up 27% from $555K YoY.","Net loss $464K vs $689K year ago; net loss per share ($0.00) vs ($0.01).","Adjusted net loss (excl. share-based comp) was $430K vs $632K.","PURE Control now treating leafy greens for commercial sale; traction in transportation with SDC-powered sanitation.","Working with distribution partners in beverage and dairy to roll out membrane treatment solutions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-027746","json":"https://secwatch.observer/filing/0001493152-25-027746.json","markdown":"https://secwatch.observer/filing/0001493152-25-027746.md","text":"https://secwatch.observer/filing/0001493152-25-027746.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006028/000149315225027746/0001493152-25-027746-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006028/000149315225027746/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:09:31.377756+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}